Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 3496 AL 3510

Levodopa Equivalent Daily Dosage: Geographical Variations and Real-Life Modules in Parkinson's Disease

Kukkle PL, Kalia LV, Habib A, Jagota P, Ojha R, Kandadai RM, Desai S, Caldera M, Sirisena D, Garg D, Mestre TA, Neupane R, Maytharakcheep S, Sanyawut K, Borgohain R.

Mov Disord Clin Pract. 2024 Nov;11(11):1388-1395. doi: 10.1002/mdc3.14200. Epub 2024 Aug 31.

Pallidal and motor cortical interactions determine gait initiation dynamics in Parkinson's disease

Bath JE, Louie KH, Azgomi HF, Balakid JP, Presbrey KN, Marks JH, Wozny TA, Wang DD.

medRxiv [Preprint]. 2024 Dec 14:2024.12.12.24318797. doi: 10.1101/2024.12.12.24318797.

RGS10 Attenuates Systemic Immune Dysregulation Induced by Chronic Inflammatory Stress

Jernigan JE, Staley HA, Baty Z, Bolen ML, Gomes BN, Holt J, Cole CL, Neighbarger NK, Dheeravath K, Merchak AR, Menees KB, Coombes SA, Tansey MG.

bioRxiv [Preprint]. 2024 Oct 29:2024.10.24.620078. doi: 10.1101/2024.10.24.620078.

Widespread Distribution of α-Synuclein Oligomers in LRRK2-related Parkinson's Disease

Sekiya H, Franke L, Hashimoto Y, Takata M, Nishida K, Futamura N, Hasegawa K, Kowa H, Ross OA, McLean PJ, Toda T, Wszolek ZK, Dickson DW.

bioRxiv [Preprint]. 2024 Dec 20:2024.12.18.629265. doi: 10.1101/2024.12.18.629265.

Parkinson's disease-associated shifts between DNA methylation and DNA hydroxymethylation in human brain in PD-related genes, including PARK19 (DNAJC6) and PTPRN2 (IA-2β)

Choza JI, Virani M, Kuhn NC, Adams M, Kochmanski J, Bernstein AI.

Res Sq [Preprint]. 2024 Jul 15:rs.3.rs-4572401. doi: 10.21203/rs.3.rs-4572401/v1.

Spirituality and Influencing Factors in Parkinson's Disease: A Scoping Review

Çavuşoğlu E, Avcı A.

J Relig Health. 2024 Jun;63(3):2091-2105. doi: 10.1007/s10943-023-01957-7. Epub 2023 Dec 2.

Novel Synthesized Tyrosinase Inhibitors: A Systematic Patent Review (2012-Present)

Beltran E, Serafini MR, Alves IA, Aragón Novoa DM.

Curr Med Chem. 2024;31(3):308-335. doi: 10.2174/0929867330666230203111437.

Comparison of the Parkinson Anxiety Scale and Other Tools to Screen Anxiety in Patients With Parkinson's Disease

Park SH.

Int J Geriatr Psychiatry. 2024 Sep;39(9):e6139. doi: 10.1002/gps.6139.

SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms

Motyl JA, Gromadzka G, Czapski GA, Adamczyk A.

Int J Mol Sci. 2024 Nov 10;25(22):12079. doi: 10.3390/ijms252212079.

LRRK2 Inhibitors as Promising Treatment for Parkinson's Disease

Tan S, Liu H, Yao X.

ACS Chem Neurosci. 2024 Nov 20;15(22):4092-4094. doi: 10.1021/acschemneuro.4c00657. Epub 2024 Nov 2.

Eyes as a window to brain pathology in parkinson's disease: a narrative review

Vidailhet M.

J Neural Transm (Vienna). 2024 Oct;131(10):1155-1158. doi: 10.1007/s00702-024-02820-z. Epub 2024 Aug 24.

Ablation of Mitochondrial RCC1-L Induces Nigral Dopaminergic Neurodegeneration and Parkinsonian-like Motor Symptoms

Ellioff KJ, Osting SMK, Lentine A, Welper AD, Burger C, Greenspan DS.

bioRxiv [Preprint]. 2024 Mar 29:2023.12.01.567409. doi: 10.1101/2023.12.01.567409.

The Effect of Sensory Reweighting on Postural Control and Cortical Activity in Parkinson's Disease

Sadeghi M, Bristow T, Fakorede S, Liao K, Palmer JA, Lyons KE, Pahwa R, Huang CK, Akinwuntan A, Devos H.

medRxiv [Preprint]. 2024 Jan 30:2024.01.26.24301687. doi: 10.1101/2024.01.26.24301687.

Brain lesions causing parkinsonism versus seizures map to opposite brain networks

Schaper FLWVJ, Morton-Dutton M, Drew W, Khosravani S, Joutsa J, Fox MD.

medRxiv [Preprint]. 2024 May 3:2024.05.02.24306764. doi: 10.1101/2024.05.02.24306764.

Neurogenic Dysphagia

Chandran SK, Doucet M.

Otolaryngol Clin North Am. 2024 Aug;57(4):589-597. doi: 10.1016/j.otc.2024.02.023. Epub 2024 Apr 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias